Daiichi Sankyo Company, Limited (DSNKY): Price and Financial Metrics


Daiichi Sankyo Company, Limited (DSNKY): $22.60

-0.73 (-3.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DSNKY Stock Price Chart Interactive Chart >

Price chart for DSNKY

DSNKY Price/Volume Stats

Current price $22.60 52-week high $38.00
Prev. close $23.33 52-week low $21.67
Day low $22.54 Volume 46,800
Day high $22.90 Avg. volume 40,193
50-day MA $25.01 Dividend yield N/A
200-day MA $29.63 Market Cap N/A

Daiichi Sankyo Company, Limited (DSNKY) Company Bio


Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment. It also provides olmesartan, an antihypertensive agent; levofloxacin, an antibacterial agent; pravastatin for hypercholesterolemia treatment; and loxoprofen, an anti-inflammatory analgesic. In addition, the company offers colesevelam for treating hypercholesterolemia and type 2 diabetes mellitus treatment; and ferric carboxymaltose and iron sucrose injections for treating anemia. Further, it provides Lulu, a combination cold remedy; Loxonin S, an antipyretic analgesic /anti-inflammatory analgesic; Transino for melasma improvement and treating against spots and freckles; Minon, a skincare product; and Breath Labo and Clean Dental oral care products, as well as Silodosin for dysuria; Gefitinib for malignant tumours; Bicalutamide for prostate cancer; and Tamoxifen, an anti-breast cancer agent. Additionally, the company offers adsorbed cell culture-derived influenza, influenza HA, measles rubella combined, and mumps vaccines. It also provides pharmaceuticals and drugs for animals, cosmetics, medical equipment, food products, drinking water, active pharmaceutical ingredients, and intermediates. The company was founded in 1899 and is headquartered in Tokyo, Japan.


DSNKY Latest News Stream


Event/Time News Detail
Loading, please wait...

DSNKY Latest Social Stream


Loading social stream, please wait...

View Full DSNKY Social Stream

DSNKY Price Returns

1-mo -6.80%
3-mo -24.87%
6-mo -29.69%
1-year -18.91%
3-year 70.52%
5-year 176.17%
YTD -34.76%
2020 57.67%
2019 105.33%
2018 22.78%
2017 28.79%
2016 -2.29%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.735 seconds.